Drugs / Metaraminol
Metaraminol
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01108874 | Nov 2009 → Aug 2010 | hypotensive disorder | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01451060 | Jun 2011 → Jun 2014 | preeclampsia | Instituto Materno Infantil Prof. Fernando Figueira | Withdrawn | No outcome recorded Stop: Business |
| Phase 43 trials | ||||||
| Phase 4 | NCT05658692 | Oct 2022 → Oct 2023 | acute respiratory distress syndrome | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
| Phase 4 | NCT05084599 | May 2022 → Jan 2024 | — | Peking University People's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04991662 | Oct → Dec 2021 | — | Xuzhou Medical University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02245191 | Jul 2014 | preeclampsia | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metaraminol | “metaraminol” NCT05658692 ↗ |
| Known as | Metaraminol hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201319 ↗ |
| Known as | Metaraminol tartrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201319 ↗ |
| Modality | Small molecule | — CHEMBL1201319 ↗ |